Chong‐De Lu
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Surgery 5
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
- Surgical site infection prevention 1
- Anesthesia and Pain Management 1
- Co-authors
- Xiaohui Fu (4 shared papers)Shuqun Cheng (9 shared papers)Wei‐Xing Guo (6 shared papers)Wan Yee Lau (8 shared papers)Xiaoping Yao (3 shared papers)Jie Xue (4 shared papers)Hongwei Zhang (1 shared paper)Hui Dong (1 shared paper)
- Journals
- Journal of Hepatology (1 paper)European Journal of Surgical Oncology (1 paper)International Journal of Surgery (1 paper)Infection Control and Hospital Epidemiology (1 paper)BMC Cancer (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Chong‐De Lu
15 papers receiving 393 citations
Chong‐De Lu's Hit Papers
Peers
Comparison fields: 5 of 45
- Hepatology 147
- Cancer Research 102
- Oncology 53
- Surgery 82
- Molecular Biology 103
Countries citing papers authored by Chong‐De Lu
This map shows the geographic impact of Chong‐De Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong‐De Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong‐De Lu more than expected).
Fields of papers citing papers by Chong‐De Lu
This network shows the impact of papers produced by Chong‐De Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong‐De Lu. The network helps show where Chong‐De Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chong‐De Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 131 | |
| 2 | Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial Hit paper breakdown → | 2024 | 77 |
| 3 | 2013 | 60 | |
| 4 | 2013 | 43 | |
| 5 | 2010 | 20 | |
| 6 | 2015 | 16 | |
| 7 | 2014 | 15 | |
| 8 | 2023 | 9 | |
| 9 | 2019 | 9 | |
| 10 | 2023 | 6 | |
| 11 | 2024 | 5 | |
| 12 | 2020 | 3 | |
| 13 | 2025 | 1 | |
| 14 | 2009 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2023 | 0 |
About Chong‐De Lu
Chong‐De Lu is a scholar working on Hepatology, Surgery, Epidemiology, Molecular Biology and Pathology and Forensic Medicine, having authored 16 papers that have together received 397 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer Mechanisms and Therapy (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Colorectal Cancer Surgical Treatments (1 paper), Surgical site infection prevention (1 paper), Cancer, Lipids, and Metabolism (1 paper) and Anesthesia and Pain Management (1 paper). The work is most often cited by research in Hepatology (147 citations), Cancer Research (102 citations), Oncology (53 citations), Surgery (82 citations) and Molecular Biology (103 citations). Chong‐De Lu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xiaohui Fu, Shuqun Cheng, Wei‐Xing Guo, Wan Yee Lau, Xiaoping Yao, Jie Xue, Hongwei Zhang, Hui Dong, Dong Xie and Jie Shi. Their work appears in journals such as Journal of Hepatology, European Journal of Surgical Oncology, International Journal of Surgery, Infection Control and Hospital Epidemiology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.